Stockreport

Is Regeneron a Multimillionaire-Maker Stock? [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF years, including the loss of patent exclusivity for one of its growth drivers, Eylea, a medicine for wet age-related macular degeneration. Even as its long-term returns [Read more]